Fujian Wanchen Biotechnology Group Co., Ltd. (SHE:300972)

SHE:300972 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	2,996	2,381	1,210	115.04	216.21	33.54
Trading Asset Securities	-	-	-	-	20.03	-
Cash & Short-Term Investments	2,996	2,381	1,210	115.04	236.24	33.54
Cash Growth	75.71%	96.80%	951.57%	-51.30%	604.37%	23.52%
Accounts Receivable	25.89	19.42	27.17	14.59	9.57	2.37
Other Receivables	52.37	66.05	122.87	4.61	0.57	0.3
Receivables	78.27	85.47	150.05	19.2	10.13	2.67
Inventory	1,453	2,141	733.29	100.11	55.37	50.8
Prepaid Expenses	-	-	-	1.48	-	-
Other Current Assets	780.01	1,163	256.2	42.87	0.64	6.12
Total Current Assets	5,308	5,771	2,349	278.69	302.39	93.13
Property, Plant & Equipment	1,235	1,271	1,371	796.9	506.33	506.01
Long-Term Investments	-	-	-	0.24	-	-
Other Intangible Assets	82.84	59.52	60.59	53.04	53.41	54.82
Long-Term Accounts Receivable	-	3.02	0.73	0.12	-	-
Long-Term Deferred Tax Assets	96.64	95.12	74.64	11.9	-	-
Long-Term Deferred Charges	37.35	37.5	51.2	4.9	-	-
Other Long-Term Assets	21.11	16.79	18.07	55.35	1.05	4.31
Total Assets	6,781	7,253	3,925	1,201	863.18	658.27
Accounts Payable	1,325	2,094	943.17	117.38	59.68	39.47
Accrued Expenses	99.58	301.32	115.67	27.06	13.18	12.4
Short-Term Debt	922.96	956.01	510.77	148.37	64.78	88.06
Current Portion of Long-Term Debt	-	12.67	9.28	6.54	30.04	61.39
Current Portion of Leases	-	155	146.03	16.17	0.08	-
Current Income Taxes Payable	260.64	208.09	54.68	0.01	5.61	-
Current Unearned Revenue	212.94	312.17	169.71	8.93	1.17	4.21
Other Current Liabilities	1,337	1,089	690.9	7.03	6	6.92
Total Current Liabilities	4,158	5,128	2,640	331.49	180.54	212.46
Long-Term Debt	372.59	237.48	148.35	110.5	-	30
Long-Term Leases	275.36	299.21	324.81	31.24	0.17	-
Long-Term Unearned Revenue	35.05	36.12	40.45	43.62	29.77	15.16
Long-Term Deferred Tax Liabilities	91.74	91.17	75.72	11.93	-	-
Total Liabilities	4,932	5,792	3,230	528.79	210.47	257.61
Common Stock	179.99	179.99	154.69	153.5	153.5	115.13
Additional Paid-In Capital	544.87	534.07	364.09	305.15	303.67	113.44
Retained Earnings	598.95	384.1	126.58	209.5	195.54	172.09
Total Common Equity	1,324	1,098	645.36	668.15	652.71	400.65
Minority Interest	524.62	363.19	50.45	4.21	-	-
Shareholders' Equity	1,848	1,461	695.81	672.36	652.71	400.65
Total Liabilities & Equity	6,781	7,253	3,925	1,201	863.18	658.27
Total Debt	1,571	1,660	1,139	312.82	95.07	179.44
Net Cash (Debt)	1,425	720.24	70.45	-197.78	141.18	-145.9
Net Cash Growth	231.40%	922.33%	-	-	-	-
Net Cash Per Share	7.34	3.85	0.46	-1.27	1.00	-1.27
Filing Date Shares Outstanding	179.99	179.99	172.39	153.5	153.5	115.13
Total Common Shares Outstanding	179.99	179.99	154.69	153.5	153.5	115.13
Working Capital	1,150	642.52	-290.99	-52.8	121.85	-119.33
Book Value Per Share	7.35	6.10	4.17	4.35	4.25	3.48
Tangible Book Value	1,241	1,039	584.77	615.11	599.3	345.84
Tangible Book Value Per Share	6.89	5.77	3.78	4.01	3.90	3.00
Buildings	-	616.41	613.66	370.04	368.64	365.76
Machinery	-	734.41	698.29	446.97	433.87	418.33
Construction In Progress	-	1.1	1.24	302.84	35.05	3.36

Source: S&P Global Market Intelligence. Standard template. Financial Sources.